FDA to launch pilot project for more transparency on generic drug delays

BETHES­DA, MD — The FDA is rolling out a new six-month pi­lot pro­gram to pro­vide more trans­paren­cy to gener­ic drug ap­pli­cants on com­pli­cat­ed reg­u­la­to­ry is­sues, Of­fice …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Hawthorne Revenue Plunges in Q1

ScottsMiracle-Gro Reports First Quarter Results Early Season Lawn and Garden Performance In-line with Expectations Company Reaffirms Full-year Non-GAAP Adjusted Gross Margin Improvement of 250 bps

Read More »